Companies /Healthcare

Regeneron Pharmaceuticals Inc

NASDAQ: REGN Biotechnology
$813.76
▼ $1.03 (−0.13%) today
Markets open · 1:49pm ET
24/7 Rating BUY
12-Month Price Target
$1,016.18 +25.1% upside

Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. How we calculate our price targets →

Current close $812.23
Street consensus $840.43
Ours vs. the Street +20.9%
$856.65Conservative$812.23Current$1,016.18Our Target$1,149.62Optimistic
12-Month Projection Historical Optimistic Target Conservative
$600$800$1,000Aug 2025Aug 2027Today$1,149.62$1,016.18$856.65
$600$800$1,000Aug 2025Aug 2027Today$1,149.62$1,016.18$856.65

Analyst Sentiment

28ANALYSTS
Buy1864%
Hold1036%
Sell00%
The Bottom Line

Regeneron appears attractively valued at current levels. With a 25.1% upside to our $1,016.18 target, the risk-reward profile looks favorable for investors with a 12-month time horizon. Wall Street agrees, with 64% of analysts rating it a Buy.

The 24/7 Factor

Base Growth
Conservative growth baseline (reduced to avoid double-counting P/E growth)
1.05×
Sector Momentum
Defensive growth with aging population tailwinds
1.10×
Analyst Consensus
Moderate analyst optimism
+3.8%
Earnings Growth
Earnings pressure
−0.4%
Volatility Adjustment
Lower volatility stock
+1.6%
Price Position
Trading near 52-week high
+1.5%
Read our full methodology →

5-Year Projection

Long-Term Forecast Optimistic Target Conservative
$900$1,200$1,500$1,800’26’27’28’29’30’31$1,834.47$1,571.02$1,022.49
$900$1,200$1,500$1,800’26’27’28’29’30’31$1,834.47$1,571.02$1,022.49

Prediction History

REGN Price Target History Our Target Stock Price
$800$1,000Jul 16Aug 21$1,020.31$834.04
$800$1,000Jul 16Aug 21$1,020.31$834.04
Date Price Target Stock Price Rating Upside
$1,020.31 $834.04 BUY +22.3%
$1,012.75 $803.48 BUY +26.1%
$976.81 $784.36 BUY +24.5%
$942.66 $762.63 BUY +23.6%
$881.00 $661.26 BUY +33.2%
$891.86 $678.94 BUY +31.4%

Frequently Asked Questions

What is the REGN stock price prediction for 2030?

Looking ahead to 2030, our model projects REGN could trade at an average price of $1,376.83, with a potential range between $1,032.62 and $1,721.04. This represents a potential 69.5% return from today’s price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.

Is REGN a buy, sell, or hold right now?

24/7 Wall St. currently rates REGN as a BUY. Strong upside (+25.1%) Among Wall Street analysts, 18 rate it Buy, 10 rate it Hold, and 0 rate it Sell.

What is the REGN stock price target in an optimistic scenario?

In our optimistic scenario for REGN, the stock could reach $1,149.62 over the next 12 months, representing a 41.5% gain from today’s price. This scenario assumes favorable conditions materialize, including strong earnings growth, positive market sentiment, and successful execution of company initiatives.

What is the downside risk for REGN stock?

Our conservative scenario for REGN projects a price of $856.65 over the next 12 months (5.5% from current levels), suggesting relatively limited downside if headwinds materialize. No forecast is a guarantee. Position sizing and time horizon still matter.

Projections are estimates based on current data, updated daily. Not investment advice. Learn how we calculate these projections →